go back

Wyoming rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $977,237 · 10th–90th $489,779–$1,071,5190%20%40%10th90th$977,237Professionalmedian $489,779 · 10th–90th $489,779–$562,3410%50%90th$489,779$500.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $489,778.82
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $562,341.33
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$512,861.38 / $602,559.59 / $602,559.59
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$812,830.52 / $977,237.22 / $1,071,519.31
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $489,778.82